Shopping Cart
- Remove All
Your shopping cart is currently empty
GRI977143 is a selective and non-lipid agonist of LPA2 (EC50 = 3.3 μM). GRI977143 inhibits the activation of caspases 3, 7, 8, and 9 and and reduces DNA fragmentation.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $33 | In Stock | |
| 5 mg | $76 | In Stock | |
| 10 mg | $133 | In Stock | |
| 25 mg | $283 | In Stock | |
| 50 mg | $455 | In Stock | |
| 100 mg | $672 | In Stock | |
| 500 mg | $1,430 | In Stock |
| Description | GRI977143 is a selective and non-lipid agonist of LPA2 (EC50 = 3.3 μM). GRI977143 inhibits the activation of caspases 3, 7, 8, and 9 and and reduces DNA fragmentation. |
| Targets&IC50 | LPA2 receptor:3.3 μM (EC50) |
| In vitro | GRI977143 (10 μM) reduces caspase 3 and 7 activation by 51% in Doxorubicin-induced apoptotic signaling in vector-transduced or LPA2-transduced MEF. GRI977143 stimulates the activation of extracellular signal-regulated kinase 1/2 and promotes the assembly of LPA2, thyroid receptor-interacting protein 6 and Na+-H+ exchange regulatory factor 2[1]. |
| Synonyms | GRI 977143 |
| Molecular Weight | 391.44 |
| Formula | C22H17NO4S |
| Cas No. | 325850-81-5 |
| Smiles | OC(=O)c1ccccc1SCCCN1C(=O)c2cccc3cccc(C1=O)c23 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | DMSO: 1 mg/mL (2.55 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
| |||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.